Cargando…
An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies
The health insurance industry in China is undergoing great shocks and profound impacts induced by the worldwide COVID-19 pandemic. Taking for instance the three dominant listed companies, namely, China Life Insurance, Ping An Insurance, and Pacific Insurance, this paper investigates the equity perfo...
Autores principales: | Ye, Rendao, An, Na, Xie, Yichen, Luo, Kun, Lin, Ya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141801/ https://www.ncbi.nlm.nih.gov/pubmed/34041217 http://dx.doi.org/10.3389/fpubh.2021.663189 |
Ejemplares similares
-
Equity incentive contract characteristics and company operational performance—An empirical study of Chinese listed companies
por: Qiao, Mingzhe, et al.
Publicado: (2023) -
Influence Analysis of Digital Financial Risk in China's Economically Developed Regions Under COVID-19: Based on the Skew-Normal Panel Data Model
por: Ye, Rendao, et al.
Publicado: (2022) -
Corporate financialization, financing constraints, and innovation efficiency—Empirical evidence based on listed Chinese pharmaceutical companies
por: Zhu, Jialin, et al.
Publicado: (2023) -
Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19
por: Li, Jianwei, et al.
Publicado: (2022) -
Does CSR affect the cost of equity capital: Empirical evidence from the targeted poverty alleviation of listed companies in China
por: Yi, Yuting, et al.
Publicado: (2020)